Botanix Pharmaceuticals Limited
BXPHF
$0.04
$0.0010.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.94M | -56.11M | -55.60M | -40.59M | -25.94M |
| Total Depreciation and Amortization | 1.50M | 1.48M | 1.47M | 1.12M | 781.10K |
| Total Amortization of Deferred Charges | 3.24M | 3.24M | 3.24M | 1.60M | -- |
| Total Other Non-Cash Items | 14.69M | 13.86M | 13.03M | 7.07M | 1.25M |
| Change in Net Operating Assets | -12.77M | -12.77M | -12.77M | -5.90M | 840.50K |
| Cash from Operations | -50.28M | -50.30M | -50.64M | -36.70M | -23.07M |
| Capital Expenditure | -125.50K | -154.30K | -183.90K | -146.40K | -110.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -287.90K | -392.40K | -504.50K | -1.54M | -2.58M |
| Cash from Investing | -413.50K | -546.80K | -688.40K | -1.69M | -2.69M |
| Total Debt Issued | 28.40M | 28.40M | 28.40M | 14.20M | -- |
| Total Debt Repaid | -337.00K | -264.80K | -192.60K | -127.10K | -61.60K |
| Issuance of Common Stock | 40.02M | 40.24M | 40.46M | 56.72M | 72.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.68M | -4.49M | -3.31M | -3.74M | -4.18M |
| Cash from Financing | 39.51M | 40.47M | 41.44M | 43.16M | 45.25M |
| Foreign Exchange rate Adjustments | -188.90K | -113.40K | -36.70K | 110.40K | 256.00K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -11.38M | -10.49M | -9.92M | 4.88M | 19.75M |